103 related articles for article (PubMed ID: 1893378)
1. All-trans-retinoic acid inhibits the growth of human rhabdomyosarcoma cell lines.
Crouch GD; Helman LJ
Cancer Res; 1991 Sep; 51(18):4882-7. PubMed ID: 1893378
[TBL] [Abstract][Full Text] [Related]
2. Insulin-like growth factors modulate the growth inhibitory effects of retinoic acid on MCF-7 breast cancer cells.
Bentel JM; Lebwohl DE; Cullen KJ; Rubin MS; Rosen N; Mendelsohn J; Miller WH
J Cell Physiol; 1995 Oct; 165(1):212-21. PubMed ID: 7559803
[TBL] [Abstract][Full Text] [Related]
3. Suramin inhibits the growth of human rhabdomyosarcoma by interrupting the insulin-like growth factor II autocrine growth loop.
Minniti CP; Maggi M; Helman LJ
Cancer Res; 1992 Apr; 52(7):1830-5. PubMed ID: 1312901
[TBL] [Abstract][Full Text] [Related]
4. 9-Cis retinoic acid inhibits growth of breast cancer cells and down-regulates estrogen receptor RNA and protein.
Rubin M; Fenig E; Rosenauer A; Menendez-Botet C; Achkar C; Bentel JM; Yahalom J; Mendelsohn J; Miller WH
Cancer Res; 1994 Dec; 54(24):6549-56. PubMed ID: 7987855
[TBL] [Abstract][Full Text] [Related]
5. Urokinase type plasminogen activator receptor is involved in insulin-like growth factor-induced migration of rhabdomyosarcoma cells in vitro.
Gallicchio MA; Kaun C; Wojta J; Binder B; Bach LA
J Cell Physiol; 2003 Oct; 197(1):131-8. PubMed ID: 12942549
[TBL] [Abstract][Full Text] [Related]
6. Down-regulation of insulin-like growth factor binding proteins and growth modulation in hepatoma cells by retinoic acid.
Kim DG; Lee DY; Cho BH; You KR; Kim MY; Ahn DS
Hepatology; 1999 Apr; 29(4):1091-8. PubMed ID: 10094952
[TBL] [Abstract][Full Text] [Related]
7. Vascular endothelial growth factor acts in an autocrine manner in rhabdomyosarcoma cell lines and can be inhibited with all-trans-retinoic acid.
Gee MF; Tsuchida R; Eichler-Jonsson C; Das B; Baruchel S; Malkin D
Oncogene; 2005 Dec; 24(54):8025-37. PubMed ID: 16116481
[TBL] [Abstract][Full Text] [Related]
8. Response of human rhabdomyosarcoma cell lines to retinoic acid: relationship with induction of differentiation and retinoic acid sensitivity.
Ricaud S; Vernus B; Bonnieu A
Exp Cell Res; 2005 Dec; 311(2):192-204. PubMed ID: 16236281
[TBL] [Abstract][Full Text] [Related]
9. Insulin-like growth factor binding protein 3 mediates retinoic acid- and transforming growth factor beta2-induced growth inhibition in human breast cancer cells.
Gucev ZS; Oh Y; Kelley KM; Rosenfeld RG
Cancer Res; 1996 Apr; 56(7):1545-50. PubMed ID: 8603400
[TBL] [Abstract][Full Text] [Related]
10. All-trans-retinoic acid-induced growth suppression of blastemal Wilms' tumor.
Vincent TS; Re GG; Hazen-Martin DJ; Tarnowski BI; Willingham MC; Garvin AJ
Pediatr Pathol Lab Med; 1996; 16(5):777-89. PubMed ID: 9025876
[TBL] [Abstract][Full Text] [Related]
11. Induction of transforming growth factor beta 1 and its receptors during all-trans-retinoic acid (RA) treatment of RA-responsive human neuroblastoma cell lines.
Cohen PS; Letterio JJ; Gaetano C; Chan J; Matsumoto K; Sporn MB; Thiele CJ
Cancer Res; 1995 Jun; 55(11):2380-6. PubMed ID: 7757990
[TBL] [Abstract][Full Text] [Related]
12. All-trans-retinoic acid inhibits the proliferation of cell lines derived from human cervical neoplasia.
Behbakht K; DeGeest K; Turyk ME; Wilbanks GD
Gynecol Oncol; 1996 Apr; 61(1):31-9. PubMed ID: 8626114
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of AIDS-Kaposi's sarcoma cell proliferation following retinoic acid receptor activation.
Guo WX; Gill PS; Antakly T
Cancer Res; 1995 Feb; 55(4):823-9. PubMed ID: 7850796
[TBL] [Abstract][Full Text] [Related]
14. Differentiation induction in the human rhabdomyosarcoma cell line TE-671. A morphological, biochemical and molecular analysis.
Ramp U; Gerharz CD; Engers R; Marx N; Gabbert HE
Anticancer Res; 1995; 15(1):181-8. PubMed ID: 7733631
[TBL] [Abstract][Full Text] [Related]
15. Insulin-like growth factor-I can mediate autocrine proliferation of human small cell lung cancer cell lines in vitro.
Nakanishi Y; Mulshine JL; Kasprzyk PG; Natale RB; Maneckjee R; Avis I; Treston AM; Gazdar AF; Minna JD; Cuttitta F
J Clin Invest; 1988 Jul; 82(1):354-9. PubMed ID: 2839551
[TBL] [Abstract][Full Text] [Related]
16. Influence of the level of gamma-glutamyltranspeptidase activity on the response of poorly and moderately differentiated rhabdomyosarcoma cell lines to all-trans-retinoic acid.
Palomares T; Castro B; del Olmo M; Iglesias A; Bilbao P; Alonso-Varona A
Anticancer Drugs; 2006 Nov; 17(10):1127-39. PubMed ID: 17075312
[TBL] [Abstract][Full Text] [Related]
17. p21WAF1 expression induced by MEK/ERK pathway activation or inhibition correlates with growth arrest, myogenic differentiation and onco-phenotype reversal in rhabdomyosarcoma cells.
Ciccarelli C; Marampon F; Scoglio A; Mauro A; Giacinti C; De Cesaris P; Zani BM
Mol Cancer; 2005 Dec; 4():41. PubMed ID: 16351709
[TBL] [Abstract][Full Text] [Related]
18. Ara-C treatment leads to differentiation and reverses the transformed phenotype in a human rhabdomyosarcoma cell line.
Crouch GD; Kalebic T; Tsokos M; Helman LJ
Exp Cell Res; 1993 Feb; 204(2):210-6. PubMed ID: 8440318
[TBL] [Abstract][Full Text] [Related]
19. Regulation of insulin-like growth factor-binding-protein-1, 2, 3, 4, 5, and 6: synthesis, secretion, and gene expression in estrogen receptor-negative human breast carcinoma cells.
Sheikh MS; Shao ZM; Hussain A; Clemmons DR; Chen JC; Roberts CT; LeRoith D; Fontana JA
J Cell Physiol; 1993 Jun; 155(3):556-67. PubMed ID: 7684042
[TBL] [Abstract][Full Text] [Related]
20. Insulin-like growth factor II acts as an autocrine growth and motility factor in human rhabdomyosarcoma tumors.
El-Badry OM; Minniti C; Kohn EC; Houghton PJ; Daughaday WH; Helman LJ
Cell Growth Differ; 1990 Jul; 1(7):325-31. PubMed ID: 2177632
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]